Oregon Zoo Elephant Tula-Tu Recovers From Virus
Veterinary staff have stopped antiviral treatment for the young Asian elephant while continuing to monitor her closely.
Updated on Nov. 16, 2026 in Pets

Oregon Zoo's young Asian elephant Tula-Tu has recovered from elephant endotheliotropic herpesvirus (EEHV), with her white blood cell counts back to normal and her viral load still declining. Veterinary staff have stopped her antiviral treatment but continue to monitor her, and she still tests positive for the virus.
Why it matters
EEHV is found in nearly all Asian elephants in the wild and in human care, and young calves are especially vulnerable as maternal antibodies decline between ages 1 and 8. Tula-Tu's recovery follows the 2018 death of her sibling Lily from the same virus, highlighting how serious the disease remains for the species.
Tula-Tu received antiviral medications, fluids and several plasma transfusions after her diagnosis approximately two weeks ago. Her blood samples are analyzed by the afternoon through a partnership with Oregon State University's Oregon Veterinary Diagnostic Laboratory, though it remains unclear how long she will continue testing positive for EEHV.
The players
Oregon Zoo
A Portland zoo that houses Tula-Tu and has supported international EEHV research for nearly 25 years.
Oregon State University's Oregon Veterinary Diagnostic Laboratory
A veterinary diagnostic laboratory that analyzes Tula-Tu's blood samples through a partnership with the zoo.
The details
Veterinary staff monitor Tula-Tu's behavior, appetite and blood results, and she is eating well and running around again. Earlier this year she became the first elephant on the West Coast to receive an mRNA vaccine against EEHV-1A.
Timeline
2018: Sibling Lily died from EEHV shortly before her sixth birthday.
2023: The zoo helped establish Sabah's first hematology laboratory with Malaysian officials.
Earlier this year: Tula-Tu received the West Coast mRNA EEHV vaccine.
Approximately two weeks before publication: Tula-Tu was diagnosed with EEHV and began treatment.
Several weeks after publication: The virus may become undetectable in Tula-Tu.
Health Landscape
The zoo's nearly 25 years of EEHV research and its 2023 hematology lab work in Sabah reflect a sustained international effort against a virus that threatens Asian elephants. Tula-Tu's case adds a West Coast example of the mRNA vaccine approach now being tested against the disease.
Monitoring of Tula-Tu's blood and behavior is continuing as treatment has stopped, so the zoo's care routine is still active. The mRNA vaccine shows a practical option for protecting young elephants, which matters for zoos managing EEHV risk in their herds.
The takeaway
Early detection and close daily monitoring of blood and behavior helped Tula-Tu recover from a disease that kills many young elephants. Vaccines and consistent veterinary care offer a path to protecting at-risk calves.
Further reading
Explore more Pet Health coverage on Portland animal care and veterinary news.






